Chevron Left
医薬品開発 に戻る

カリフォルニア大学サンディエゴ校 による 医薬品開発 の受講者のレビューおよびフィードバック

4.7
2,079件の評価

コースについて

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Development course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug development. In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), New Drug Application (NDA), and product labeling. Additionally you will learn how to Incorporate study design methods for consideration in the design of clinical protocols to assess safety, tolerability, and efficacy in multiple therapeutic areas. In this course you will learn the different phases of clinical development: * Phase 1 or early stage clinical trial are conducted primar­ily to determine how the new drug works in humans, its safety profile and to predict its dosage range. It typically involves between 30 and 100 healthy volunteers. * Phase 2 or Proof of Concept POC studies test for efficacy as well as safety and side effects in a group of between 30 to 200 hundred patients with the disease for which the new drug is being developed. * Phase 3 or late stage clinical development involve much larger group of patients, between a few hundred to thousands, depending on the indication, which will help determine if the new drug can be considered both safe and effective. It will involve control groups using placebo and/or current treatment as a comparison. * Product registration and approval process after a drug is considered safe and effective from Phase 3 trials, it must be authorized in each individual country before it can be marketed. All data gen­erated about the small molecule or biologic is collected and submitted to the regulatory authorities in the US at the FDA, Food and Drug Administration FDA, in Europe the EMA or European Medicines Agency, Japan Ministry of Health and other countries which may require their own national approvals. This course is intended as part 2 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development and Drug Commercialization (https://www.coursera.org/learn/drug-commercialization). We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place....

人気のレビュー

KR

2020年5月24日

I am really glad to have course offered by california university . Its really helpful for me. And i am thankful to all lecturer, and teachers to explain overall drug development process.

Thank you!

HG

2018年10月15日

Very well done and informative. I truly appreciate the Drug process in entirety being broken down into sections that are easy to comprehend. It is obvious the speakers were chosen for their knowledge.

フィルター:

医薬品開発: 1 - 25 / 414 レビュー

by Ekaterine B

2018年2月20日

by Cynthia V

2020年1月28日

by shaurya b

2019年1月23日

by Humberto M

2018年2月26日

by Dr.V.Padmavathi

2020年7月4日

by Miriam C

2019年5月8日

by Jesse G

2021年1月18日

by Philip R

2018年12月2日

by Adrián P F

2018年11月12日

by Emily K

2020年1月23日

by Dr. H R

2018年8月29日

by Michael D

2018年9月2日

by ANTONIOS M N C

2018年6月3日

by HASAN B

2020年3月8日

by Heather G

2018年10月16日

by Shyam P

2019年9月14日

by Giridhar R G

2020年5月2日

by Ahmed I I

2019年12月30日

by Radwa A M A E

2019年9月21日

by ABHINAV S

2020年4月26日

by Franceska F

2020年1月12日

by ELENA F D

2020年4月29日

by Yurshanva K

2019年9月3日

by Rosa E H E

2019年8月7日

by Bhavana S

2020年7月2日